Senators Bring Back Bill Mandating Medicare Payment For Breakthrough Technologies
Executive Summary
Four US senators are leading a bipartisan effort to bring potentially life-saving medical treatments to Medicare beneficiaries by requiring reimbursement for breakthrough technologies cleared by the FDA.
You may also be interested in...
Cures 2.0 Would Circumvent CMS’ Pause On Breakthrough Payment Rule, Improve Telehealth, And More
A new medical research bill proposed by US lawmakers would push through a delayed but highly anticipated CMS policy requiring payment for breakthrough devices.
MCIT Rule Likely Too Broken For CMS To Implement In December, Analyst Predicts
John Leppard with Washington Analysis says the Medicare agency’s recent delay of the MCIT breakthrough devices rule until mid-December suggests the CMS will likely scrap it altogether and start from scratch.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.